Literature DB >> 33531212

Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).

Lori J Ducharme1, Tisha R A Wiley2, Carrie F Mulford2, Zu-In Su2, Julia B Zur2.   

Abstract

Many individuals with opioid use disorder come into contact with the justice system each year, making the nexus between the criminal justice system and the health care system a critical juncture for responding to the opioid crisis and simultaneously promoting public health and public safety. Collaborations across these sectors are essential to providing effective screening, treatment, and discharge planning; connecting individuals to services following release; promoting long-term recovery while reducing recidivism; and ultimately bringing the opioid crisis under control. In 2019, with the support of the NIH Helping to End Addiction Long-term (HEAL) Initiative, the National Institute on Drug Abuse launched the Justice Community Opioid Innovation Network (JCOIN). JCOIN is a >$150M multisite cooperative designed to facilitate transdisciplinary collaborations that can create actionable, translatable insights for the justice system and community-based organizations to address the opioid epidemic in justice-involved populations. JCOIN brings together 11 Research Hubs, a coordination and translation center (CTC), and a methodology and advanced analytics resource center (MAARC), with the goal of generating evidence that is greater than the sum of the parts. Collectively, the network will field at least 12 large-scale multisite clinical trials, which are described in this special issue. This article provides a brief overview of the scientific underpinnings for these trials; describes the broad themes connecting them; and discusses the intersections of the JCOIN initiative with the COVID-19 pandemic. Published by Elsevier Inc.

Entities:  

Keywords:  Addiction treatment; Clinical trials; Implementation science; Justice system; Opioid use disorder

Mesh:

Substances:

Year:  2021        PMID: 33531212      PMCID: PMC9096711          DOI: 10.1016/j.jsat.2021.108307

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

Review 1.  Implementing Opioid Agonist Treatment in Correctional Facilities.

Authors:  Kevin Fiscella; Sarah E Wakeman; Leo Beletsky
Journal:  JAMA Intern Med       Date:  2018-09-01       Impact factor: 21.873

2.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

3.  The Benefits of Community and Juvenile Justice Involvement in Organizational Research.

Authors:  Carl G Leukefeld; Margaret Cawood; Tisha Wiley; Angela A Robertson; Jacqueline Horan Fisher; Nancy Arrigona; Patricia Donohue; Michelle Staples-Horne; Philip W Harris; Richard Dembo; Judy Roysden; Katherine R Marks
Journal:  J Juv Justice       Date:  2017

4.  Opportunities and challenges in conducting community-engaged dissemination/implementation research.

Authors:  Cheryl L Holt; David A Chambers
Journal:  Transl Behav Med       Date:  2017-09       Impact factor: 3.046

5.  Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.

Authors:  Kelly E Moore; Walter Roberts; Holly H Reid; Kathryn M Z Smith; Lindsay M S Oberleitner; Sherry A McKee
Journal:  J Subst Abuse Treat       Date:  2018-12-15

6.  Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.

Authors:  John Marsden; Garry Stillwell; Hayley Jones; Alisha Cooper; Brian Eastwood; Michael Farrell; Tim Lowden; Nino Maddalena; Chris Metcalfe; Jenny Shaw; Matthew Hickman
Journal:  Addiction       Date:  2017-03-01       Impact factor: 6.526

7.  Peer Workers in the Behavioral and Integrated Health Workforce: Opportunities and Future Directions.

Authors:  Cheryl A Gagne; Wanda L Finch; Keris J Myrick; Livia M Davis
Journal:  Am J Prev Med       Date:  2018-06       Impact factor: 5.043

8.  Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Authors:  Traci C Green; Jennifer Clarke; Lauren Brinkley-Rubinstein; Brandon D L Marshall; Nicole Alexander-Scott; Rebecca Boss; Josiah D Rich
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 25.911

Review 9.  A conceptual model for understanding post-release opioid-related overdose risk.

Authors:  Paul J Joudrey; Maria R Khan; Emily A Wang; Joy D Scheidell; E Jennifer Edelman; D Keith McInnes; Aaron D Fox
Journal:  Addict Sci Clin Pract       Date:  2019-04-15

10.  Collision of the COVID-19 and Addiction Epidemics.

Authors:  Nora D Volkow
Journal:  Ann Intern Med       Date:  2020-04-02       Impact factor: 25.391

View more
  3 in total

1.  Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes.

Authors:  Hannah Cheng; Mark P McGovern; Hélène Chokron Garneau; Brian Hurley; Tammy Fisher; Meaghan Copeland; Daniel Almirall
Journal:  Implement Sci Commun       Date:  2022-07-06

Review 2.  Scoping review of interventions to link individuals to substance use services at discharge from jail.

Authors:  Christine E Grella; Erika Ostlie; Dennis P Watson; Christy K Scott; John Carnevale; Michael L Dennis
Journal:  J Subst Abuse Treat       Date:  2022-01-04

3.  Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Dennis P Watson
Journal:  J Subst Abuse Treat       Date:  2020-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.